{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:06:06Z","timestamp":1790143566661,"version":"4.0.1"},"reference-count":50,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62372144"],"award-info":[{"award-number":["62372144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62573169"],"award-info":[{"award-number":["62573169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62572155"],"award-info":[{"award-number":["62572155"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["62372144"],"award-info":[{"award-number":["62372144"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["62573169"],"award-info":[{"award-number":["62573169"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["62572155"],"award-info":[{"award-number":["62572155"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Outstanding Youth Foundation of Heilongjiang Province","award":["YQ2023F004"],"award-info":[{"award-number":["YQ2023F004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>With the rapid development of cancer treatment, immunotherapy has revolutionized renal cell carcinoma (RCC) treatment, yet patient responses remain heterogeneous. Here, a computational pipeline was constructed by integrating single-cell and bulk RNA sequencing data to identify immune-related candidate driver genes and characterize their impact on RCC immunotherapy. Based on gene regulatory networks (GRN), 25 immune-related candidate driver genes were identified, leading to the stratification of patients into three clusters (C1\u2013C3). Compared to the C2\/C3 cluster, the C1 cluster exhibited elevated immune infiltration, tumor mutation burden and checkpoint expression, which may represent immunotherapy responders. Dynamic analysis of GRNs revealed the critical role of candidate driver genes in predicting the efficacy of immunotherapy. IRF1, IRF9 and STAT1 in lymphoid cells of C1 participated in anti-tumor immune response by impacting target genes CD8A, HLA-A\/E, TAP1 and PD-1. JUN, FOS, STAT3, JUND and NR2F1 were up-regulated in clusters C2 and C3, leading to tumor progression and immune evasion by influencing target genes HSPA1A, CXCL9 and PDGFR. In conclusion, integration of the transcriptome with molecular networks provided a network-based framework to uncover immune-related candidate driver genes for stratifying RCC patients, thereby serving as potential therapeutic targets to improve the outcome of RCC immunotherapy.<\/jats:p>","DOI":"10.3390\/ijms27083467","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:49:02Z","timestamp":1776070142000},"page":"3467","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of Cell Subpopulation-Specific Driver Genes Reveals Ideal Candidates for Renal Cell Carcinoma Immunotherapy"],"prefix":"10.3390","volume":"27","author":[{"given":"Xiangzhe","family":"Yin","sequence":"first","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2005-4651","authenticated-orcid":false,"given":"Yanwu","family":"Sun","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyi","family":"Li","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentong","family":"Yu","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Geng","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1936-8513","authenticated-orcid":false,"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of Renal Cell Carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jare.2021.11.016","article-title":"Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma","volume":"40","author":"Long","year":"2022","journal-title":"J. Adv. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e010183","DOI":"10.1136\/jitc-2024-010183","article-title":"Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma","volume":"13","author":"Song","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1158\/1535-7163.MCT-17-1299","article-title":"Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies","volume":"17","author":"Makhov","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12943-023-01926-4","article-title":"Evolving insights into the improvement of adoptive T-cell immunotherapy through PD-1\/PD-L1 blockade in the clinical spectrum of lung cancer","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/jso.26339","article-title":"Immune checkpoint blockade in renal cell carcinoma","volume":"123","author":"Rappold","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zarrabi, K.K., Lanade, O., and Geynisman, D.M. (2022). Determining Front-Line Therapeutic Strategy for Metastatic Clear Cell Renal Cell Carcinoma. Cancers, 14.","DOI":"10.3390\/cancers14194607"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e002954","DOI":"10.1136\/jitc-2021-002949","article-title":"CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma","volume":"9","author":"Klumper","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41571-020-00455-z","article-title":"Beyond conventional immune-checkpoint inhibition\u2014Novel immunotherapies for renal cell carcinoma","volume":"18","author":"Braun","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","article-title":"Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma","volume":"39","author":"Bi","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Han, B., Liu, W., Wang, W., Li, Z., You, B., Liu, D., Nan, Y., Ding, T., Dai, Z., and Zhang, Y. (2025). CRISPR\/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysis. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1619361"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"217514","DOI":"10.1016\/j.canlet.2025.217514","article-title":"Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3\/BCL-XL pathway","volume":"613","author":"Xue","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","article-title":"The present and future of the Cancer Dependency Map","volume":"25","author":"Arafeh","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/14728222.2018.1471137","article-title":"Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells","volume":"22","author":"Toor","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/2326-6066.CIR-18-0711","article-title":"IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell","volume":"7","author":"Shao","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbrc.2020.03.069","article-title":"CSK promotes innate immune response to DNA virus by phosphorylating MITA","volume":"526","author":"Gao","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13046-022-02449-4","article-title":"Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun\/c-Fos\/SREBP1 axis in gastric cancer","volume":"41","author":"Jia","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12943-019-0976-4","article-title":"Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis","volume":"18","author":"Wei","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ijc.31763","article-title":"Senescence markers: Predictive for response to checkpoint inhibitors","volume":"144","author":"Moreira","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1007\/s12272-016-0854-1","article-title":"Essential role of interferon regulatory factor 4 (IRF4) in immune cell development","volume":"39","author":"Nam","year":"2016","journal-title":"Arch. Pharm. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Karin, N. (2021). Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?. Cancers, 13.","DOI":"10.3390\/cancers13246317"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1158\/0008-5472.CAN-17-3102","article-title":"Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance","volume":"78","author":"Hibino","year":"2018","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e06395","DOI":"10.1016\/j.heliyon.2021.e06395","article-title":"In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors","volume":"7","author":"Laha","year":"2021","journal-title":"Heliyon"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"D46","DOI":"10.1093\/nar\/gkac1067","article-title":"ChIPBase v3.0: The encyclopedia of transcriptional regulations of non-coding RNAs and protein-coding genes","volume":"51","author":"Huang","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"eaax7881","DOI":"10.1126\/sciadv.aax7881","article-title":"Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1\/PD-L1 immunotherapy","volume":"6","author":"Noman","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"215598","DOI":"10.1016\/j.canlet.2022.215598","article-title":"PMN-MDSCs accumulation induced by CXCL1 promotes CD8(+) T cells exhaustion in gastric cancer","volume":"532","author":"Zhou","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Zhang, J., Zhang, J., Zhao, W., Li, Q., and Cheng, W. (2022). Low expression of NR1H3 correlates with macrophage infiltration and indicates worse survival in breast cancer. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.1067826"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1002\/tox.24262","article-title":"Elucidating the role of FOS in modulating the immune microenvironment through fibroblast and myeloid cell regulation in locoregional recurrent HNSCC","volume":"39","author":"Liu","year":"2024","journal-title":"Environ. Toxicol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/hep.32444","article-title":"Single-cell profiling of human CD127(+) innate lymphoid cells reveals diverse immune phenotypes in hepatocellular carcinoma","volume":"76","author":"He","year":"2022","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"120057","DOI":"10.1016\/j.lfs.2021.120057","article-title":"The impact of hypoxia on immune state in cancer","volume":"286","author":"Mortezaee","year":"2021","journal-title":"Life Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ijbiomac.2022.01.113","article-title":"Targeting the PDGF\/PDGFR signaling pathway for cancer therapy: A review","volume":"202","author":"Zou","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1111\/jcmm.16479","article-title":"Single-cell analysis reveals metastatic cell heterogeneity in clear cell renal cell carcinoma","volume":"25","author":"Liu","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e18248","DOI":"10.1111\/jcmm.18248","article-title":"Prognostic and immunotherapeutic potential of regulatory T cell-associated signature in ovarian cancer","volume":"28","author":"Liu","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"D\u2019Amico, S., Tempora, P., Melaiu, O., Lucarini, V., Cifaldi, L., Locatelli, F., and Fruci, D. (2022). Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.948297"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2022.01.027","article-title":"HIF-1alpha inhibition promotes the efficacy of immune checkpoint blockade in the treatment of non-small cell lung cancer","volume":"531","author":"Luo","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","article-title":"A scalable SCENIC workflow for single-cell gene regulatory network analysis","volume":"15","author":"Flerin","year":"2020","journal-title":"Nat. Protoc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1038\/s41467-021-25618-z","article-title":"Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma","volume":"12","author":"Sun","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"180015","DOI":"10.1038\/sdata.2018.15","article-title":"ImmPort, toward repurposing of open access immunological assay data for translational and clinical research","volume":"5","author":"Bhattacharya","year":"2018","journal-title":"Sci. Data"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41591-020-0839-y","article-title":"Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma","volume":"26","author":"Braun","year":"2020","journal-title":"Nat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: Single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nbt1203","article-title":"Gene prioritization through genomic data fusion","volume":"24","author":"Aerts","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/biostatistics\/kxj029","article-title":"Are clusters found in one dataset present in another dataset?","volume":"8","author":"Kapp","year":"2007","journal-title":"Biostatistics"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-021-01310-0","article-title":"Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development","volume":"20","author":"Huang","year":"2021","journal-title":"Mol. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Hanzelmann, S., Castelo, R., and Guinney, J. (2013). GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform., 14.","DOI":"10.1186\/1471-2105-14-7"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/8\/3467\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:05:04Z","timestamp":1776071104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/8\/3467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["ijms27083467"],"URL":"https:\/\/doi.org\/10.3390\/ijms27083467","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]}}}